H49.42

Clinical Causes: Genetic mutations affecting mitochondrial function, inherited in an autosomal dominant pattern. Mitochondrial myopathies, which are disorders caused by dysfunctional mitochondria within muscle cells. Sporadic mutations or mitochondrial DNA deletions that occur de novo without family history. Associated syndromes such as Kearns-Sayre syndrome and other mitochondrial syndromes.

Key Symptoms: Progressive weakness of the external eye muscles leading to limited eye movement. Ptosis, or drooping of the eyelid, which may become more prominent over time. Difficulty in moving the eye in different directions, such as looking upward, downward, or side-to-side. Double vision (diplopia) due to misalignment of the eyes. Possible mild facial weakness or muscle weakness in other parts of the body in some cases. Symptoms tend to develop gradually, often over weeks or months.

Diagnosis Path: Diagnosis of progressive external ophthalmoplegia involves a combination of clinical evaluation and testing, including: - Detailed medical history and physical examination focusing on eye movement and eyelid function. - Eye movement tests to assess range and strength. - Fundoscopy to examine the retina and optic nerve. - Electromyography (EMG) to evaluate muscle activity. - Blood tests for markers of mitochondrial function. - Muscle biopsies in certain cases to identify mitochondrial abnormalities. - Genetic testing to identify specific mitochondrial DNA mutations or deletions associated with the condition.

Treatment Protocols: While there is no cure for progressive external ophthalmoplegia, management strategies aim to reduce symptoms and improve functioning: - Corrective glasses or prisms to help with double vision. - Surgical procedures such as eyelid surgery for ptosis if it significantly affects vision. - Use of eye patches to manage double vision. - Regular visual and neurological assessments. - Supportive care, including physical therapy and occupational therapy, to address associated muscle weakness. - Emerging treatments and clinical trials focusing on mitochondrial health are under investigation. Patients are advised to work closely with medical specialists in neurology and ophthalmology for personalized care plans.